Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy chain variable region (IGHV) pseudogenes are segments of DNA located within the immunoglobulin heavy chain locus (14q32.33) that resemble functional IGHV genes but carry mutations or deletions that prevent them from encoding a functional immunoglobulin heavy chain variable domain. These pseudogenes are considered evolutionary remnants and do not produce protein products. They may appear in next-generation sequencing studies or immunogenomic analyses, but they do not contribute to the immune repertoire or serve as therapeutic targets. The designation "novel IGHV pseudogene" likely refers to a newly annotated or previously uncharacterized pseudogene in this locus, rather than a distinct biological entity with function or therapeutic relevance. The IMGT database catalogues several human IGHV pseudogenes, all explicitly labeled as pseudogenes with the status "P" for functionality (non-functional), located at chromosomal region 14q32.33. These pseudogenes may create annotation challenges in immunoinformatics but are not included in functional gene sets for therapeutic targeting or biomarker development. Use of ENSG00000271691 as a "therapeutic target" or "receptor" is not scientifically accurate; for structured applications, this entry should be flagged as a pseudogene and not a valid target. ENSG00000271691 ("novel IGHV pseudogene") should be treated as a pseudogene related to the immunoglobulin family, not as a functional molecule or therapeutic target; most fields (including drugs, function, disease roles) are not applicable.
None (pseudogenes are not targeted therapeutically)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable region pseudogene (IGHV pseudogene).